Source: Manufacturing Chemist

AGC Biologics: ACG Biologics launches Cell and Gene Technologies Division

The CDMO's division will be responsible for assisting the biopharmaceutical industry in developing and commercialising cell and gene therapies at a competitive cost

Read full article »
Est. Annual Revenue
$100-500M
Est. Employees
1.0-5.0K
Alberto Santagostino's photo - President & CEO of AGC Biologics

President & CEO

Alberto Santagostino

CEO Approval Rating

82/100

Read more